Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-I Huang

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Journal of Clinical and Translational Hepatology|November 15, 2024
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic HepatitisChung-Feng Huang, Konstantin Kroeniger, Chih-Wen Wang, et al.
BMC Infectious Diseases|June 6, 2026
Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in UgandaChing-I Huang, Marina Antillon, Ronald E Crump, et al.
Plos Neglected Tropical Diseases|July 27, 2023
Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of ChadMarina Antillon, Ching-I Huang, Samuel A Sutherland, et al.
Open Forum Infectious Diseases|September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus InfectionsPo-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Scientific Reports|March 12, 2016
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis CMing-Ying Lu, Ching-I Huang, Chia-Yen Dai, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Journal of Clinical and Translational Hepatology|November 15, 2024
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic HepatitisChung-Feng Huang, Konstantin Kroeniger, Chih-Wen Wang, et al.
BMC Infectious Diseases|June 6, 2026
Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in UgandaChing-I Huang, Marina Antillon, Ronald E Crump, et al.
Plos Neglected Tropical Diseases|July 27, 2023
Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of ChadMarina Antillon, Ching-I Huang, Samuel A Sutherland, et al.
Open Forum Infectious Diseases|September 3, 2020
Viral Interference Between Dengue Virus and Hepatitis C Virus InfectionsPo-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Scientific Reports|March 12, 2016
Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis CMing-Ying Lu, Ching-I Huang, Chia-Yen Dai, et al.
Pageof 16